AUTL analyst estimates

Autolus Therapeutics (AUTL) analyst ratings, the average price target and its range, and every firm's latest call.

AUTL analyst ratings and price targets

DateFirmCallTarget
Nov 18, 2024Goldman SachsGoldman Sachs Upgrades Autolus Therapeutics plc (AUTL) to Buy$7.60
May 20, 2024Wells FargoWells Fargo Reiterates Overweight Rating on Autolus Therapeutics plc (AUTL)$8.00
Apr 8, 2024Truist FinancialAutolus Therapeutics plc (AUTL) PT Raised to $11 at Truist Securities$11.00
Mar 15, 2024Truist FinancialAutolus Therapeutics plc (AUTL) PT Raised to $10 at Truist Securities$10.00